Literature DB >> 9843497

A single amino acid substitution in a WW-like domain of diverse members of the PDGF receptor subfamily of tyrosine kinases causes constitutive receptor activation.

P M Irusta1, D DiMaio.   

Abstract

Platelet-derived growth factor beta receptor (PDGFbetaR) is a transmembrane receptor tyrosine kinase involved in a variety of cellular functions. We have generated a constitutively activated murine PDGFbetaR containing a valine to alanine substitution at residue 536, located in the cytoplasmic juxtamembrane domain. When this mutant receptor (PR-V536A) was expressed in Ba/F3 cells, it allowed the cells to survive and proliferate in the absence of IL-3 or PDGF, and tyrosine phosphorylation of PR-V536A was increased markedly compared with that of the wild-type PDGFbetaR in the absence of ligand and similar to that observed in ligand-activated PDGFbetaR. PR-V536A displayed increased tyrosine kinase activity in vitro toward an exogenous substrate, and the tyrosine kinase activity of the receptor was required for the constitutive activation of the mutant. This valine to alanine substitution also activated a PDGFbetaR mutant unable to bind PDGF. Alanine substitutions at positions homologous to V536 of the murine PDGFbetaR also activated other members of the PDGF receptor subfamily. The amino acid sequence of this region revealed a strong similarity to WW domains present in other signal transduction proteins. Furthermore, GST fusion proteins containing the juxtamembrane region of the PDGFR specifically associated with peptides containing the WW domain consensus recognition sequence PPXY. The results suggest that the cytoplasmic juxtamembrane domain plays a role in the regulation of receptor activity and function, perhaps by participating in protein-protein interactions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9843497      PMCID: PMC1171039          DOI: 10.1093/emboj/17.23.6912

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  41 in total

1.  Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties.

Authors:  W G Kaelin; W Krek; W R Sellers; J A DeCaprio; F Ajchenbaum; C S Fuchs; T Chittenden; Y Li; P J Farnham; M A Blanar
Journal:  Cell       Date:  1992-07-24       Impact factor: 41.582

2.  Ligand-independent activation of the platelet-derived growth factor beta receptor: requirements for bovine papillomavirus E5-induced mitogenic signaling.

Authors:  D Drummond-Barbosa; R R Vaillancourt; A Kazlauskas; D DiMaio
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

3.  The GTPase-activating protein of Ras suppresses platelet-derived growth factor beta receptor signaling by silencing phospholipase C-gamma 1.

Authors:  M Valius; J P Secrist; A Kazlauskas
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

4.  Specific interaction between the bovine papillomavirus E5 transforming protein and the beta receptor for platelet-derived growth factor in stably transformed and acutely transfected cells.

Authors:  L Petti; D DiMaio
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

5.  Catalytic specificity of protein-tyrosine kinases is critical for selective signalling.

Authors:  Z Songyang; K L Carraway; M J Eck; S C Harrison; R A Feldman; M Mohammadi; J Schlessinger; S R Hubbard; D P Smith; C Eng
Journal:  Nature       Date:  1995-02-09       Impact factor: 49.962

6.  Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation.

Authors:  M Kovalenko; A Gazit; A Böhmer; C Rorsman; L Rönnstrand; C H Heldin; J Waltenberger; F D Böhmer; A Levitzki
Journal:  Cancer Res       Date:  1994-12-01       Impact factor: 12.701

7.  Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo.

Authors:  R Palacios; M Steinmetz
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

8.  Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B.

Authors:  M Santoro; F Carlomagno; A Romano; D P Bottaro; N A Dathan; M Grieco; A Fusco; G Vecchio; B Matoskova; M H Kraus
Journal:  Science       Date:  1995-01-20       Impact factor: 47.728

9.  Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines.

Authors:  H Kitayama; Y Kanakura; T Furitsu; T Tsujimura; K Oritani; H Ikeda; H Sugahara; H Mitsui; Y Kanayama; Y Kitamura
Journal:  Blood       Date:  1995-02-01       Impact factor: 22.113

10.  CD45 protein-tyrosine phosphatase associates with the WW domain-containing protein, CD45AP, through the transmembrane region.

Authors:  E D Cahir McFarland; M L Thomas
Journal:  J Biol Chem       Date:  1995-11-24       Impact factor: 5.157

View more
  11 in total

1.  Increased PDGFRalpha activation disrupts connective tissue development and drives systemic fibrosis.

Authors:  Lorin E Olson; Philippe Soriano
Journal:  Dev Cell       Date:  2009-02       Impact factor: 12.270

Review 2.  The emerging complexity of PDGFRs: activation, internalization and signal attenuation.

Authors:  Madison A Rogers; Katherine A Fantauzzo
Journal:  Biochem Soc Trans       Date:  2020-06-30       Impact factor: 5.407

3.  PDGFRβ signaling regulates mural cell plasticity and inhibits fat development.

Authors:  Lorin E Olson; Philippe Soriano
Journal:  Dev Cell       Date:  2011-06-14       Impact factor: 12.270

4.  A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3'-kinase activation and endothelial cell migration.

Authors:  H Gille; J Kowalski; L Yu; H Chen; M T Pisabarro; T Davis-Smyth; N Ferrara
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

5.  Critical role of the platelet-derived growth factor receptor (PDGFR) beta transmembrane domain in the TEL-PDGFRbeta cytosolic oncoprotein.

Authors:  Federica Toffalini; Carina Hellberg; Jean-Baptiste Demoulin
Journal:  J Biol Chem       Date:  2010-02-17       Impact factor: 5.157

6.  Activation of the PDGF β Receptor by a Persistent Artificial Signal Peptide.

Authors:  Lisa M Petti; Benjamin N Koleske; Daniel DiMaio
Journal:  J Mol Biol       Date:  2021-08-30       Impact factor: 6.151

7.  BAD is a pro-survival factor prior to activation of its pro-apoptotic function.

Authors:  So Young Seo; Ying-Bei Chen; Iva Ivanovska; Ann M Ranger; Suk J Hong; Valina L Dawson; Stanley J Korsmeyer; David S Bellows; Yihru Fannjiang; J Marie Hardwick
Journal:  J Biol Chem       Date:  2004-07-01       Impact factor: 5.157

8.  Autoinhibition of the kit receptor tyrosine kinase by the cytosolic juxtamembrane region.

Authors:  Perry M Chan; Subburaj Ilangumaran; Jose La Rose; Avijit Chakrabartty; Robert Rottapel
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

9.  KIT Mutation and Loss of 14q May Be Sufficient for the Development of Clinically Symptomatic Very Low-Risk GIST.

Authors:  Olaf Karl Klinke; Tuba Mizani; Gouri Baldwin; Brigitte Bancel; Mojgan Devouassoux-Shisheboran; Jean-Yves Scoazec; Pierre-Paul Bringuier; Regina Feederle; Anna Jauch; Katrin Hinderhofer; Philippe Taniere; Henri-Jacques Delecluse
Journal:  PLoS One       Date:  2015-06-23       Impact factor: 3.240

Review 10.  Class III Receptor Tyrosine Kinases in Acute Leukemia - Biological Functions and Modern Laboratory Analysis.

Authors:  Rimma Berenstein
Journal:  Biomark Insights       Date:  2015-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.